Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.

Thumbnail
Date
2006-Aug
Author
H Pakdaman
A Fallah
M A Sahraian
R Pakdaman
A Meysamie
Metadata
Show full item record
Abstract
Patients with early onset multiple sclerosis may develop disability at a younger age than adults. There are several reports about safety of beta interferons in childhood and juvenile MS with different doses.
Collections